JD Health International Inc. (HKG:6618)
46.88
-2.10 (-4.29%)
Apr 22, 2026, 4:08 PM HKT
JD Health International Revenue
In the year 2025, JD Health International had annual revenue of 73.44B CNY with 26.28% growth. JD Health International had revenue of 38.15B in the half year ending December 31, 2025, with 44.41% growth.
Revenue
73.44B CNY
Revenue Growth
+26.28%
P/S Ratio
1.92
Revenue / Employee
13.95M CNY
Employees
5,263
Market Cap
157.26B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 73.44B | 15.28B | 26.28% |
| Dec 31, 2024 | 58.16B | 4.63B | 8.65% |
| Dec 31, 2023 | 53.53B | 6.79B | 14.54% |
| Dec 31, 2022 | 46.74B | 16.05B | 52.32% |
| Dec 31, 2021 | 30.68B | 11.30B | 58.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alibaba Health Information Technology | 36.09B |
| YSB Inc. | 23.34B |
| Fangzhou | 3.92B |
| Shanghai Pioneer Holding | 1.43B |
| Tycoon Group Holdings | 1.10B |
| Kingworld Medicines Group | 1.02B |
| Universal Health International Group Holding | 597.78M |
| New Ray Medicine International Holding | 130.37M |
JD Health International News
- 2 years ago - ‘The China equity trade is back' and here are the stocks to pick, says SocGen - Market Watch